G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 115 filers reported holding G1 THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $307 | -95.5% | 213 | -92.2% | 0.00% | – |
| Q2 2023 | $6,757 | -60.0% | 2,714 | -56.9% | 0.00% | – |
| Q1 2023 | $16,887 | -61.0% | 6,301 | -21.1% | 0.00% | – |
| Q4 2022 | $43,348 | -93.8% | 7,983 | -85.7% | 0.00% | – |
| Q3 2022 | $700,000 | +69900.0% | 55,983 | +26183.1% | 0.00% | – |
| Q2 2022 | $1,000 | -99.9% | 213 | -99.9% | 0.00% | -100.0% |
| Q1 2022 | $1,694,000 | -35.6% | 222,919 | -13.5% | 0.00% | 0.0% |
| Q4 2021 | $2,631,000 | +62.6% | 257,719 | +113.8% | 0.00% | 0.0% |
| Q3 2021 | $1,618,000 | +383.0% | 120,562 | +688.6% | 0.00% | – |
| Q2 2021 | $335,000 | -79.0% | 15,288 | -77.0% | 0.00% | -100.0% |
| Q1 2021 | $1,599,000 | +39875.0% | 66,471 | +31107.0% | 0.00% | – |
| Q4 2020 | $4,000 | -93.3% | 213 | -95.9% | 0.00% | – |
| Q3 2020 | $60,000 | +57.9% | 5,213 | +233.1% | 0.00% | – |
| Q2 2020 | $38,000 | -67.8% | 1,565 | -85.4% | 0.00% | – |
| Q1 2020 | $118,000 | -83.7% | 10,726 | -60.9% | 0.00% | – |
| Q4 2019 | $725,000 | -52.2% | 27,410 | -58.9% | 0.00% | -100.0% |
| Q3 2019 | $1,518,000 | +189.7% | 66,671 | +290.5% | 0.00% | – |
| Q2 2019 | $524,000 | +4266.7% | 17,073 | +2294.5% | 0.00% | – |
| Q1 2019 | $12,000 | -99.3% | 713 | -99.2% | 0.00% | -100.0% |
| Q4 2018 | $1,803,000 | +344.1% | 94,141 | +1113.0% | 0.00% | – |
| Q3 2018 | $406,000 | +327.4% | 7,761 | +253.9% | 0.00% | – |
| Q2 2018 | $95,000 | +137.5% | 2,193 | +99.4% | 0.00% | – |
| Q1 2018 | $40,000 | +48.1% | 1,100 | -18.8% | 0.00% | – |
| Q4 2017 | $27,000 | +170.0% | 1,354 | +238.5% | 0.00% | – |
| Q3 2017 | $10,000 | -33.3% | 400 | -55.3% | 0.00% | – |
| Q2 2017 | $15,000 | – | 895 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 994,287 | $19,041,000 | 1.55% |
| HHLR ADVISORS, LTD. | 949,431 | $18,182,000 | 0.75% |
| BB BIOTECH AG | 671,925 | $12,867,000 | 0.41% |
| Rhenman & Partners Asset Management AB | 172,820 | $3,310,000 | 0.38% |
| Birchview Capital, LP | 15,000 | $287,000 | 0.27% |
| Rock Springs Capital Management LP | 100,000 | $1,915,000 | 0.09% |
| SECOR Capital Advisors, LP | 32,591 | $624,000 | 0.08% |
| MARSHALL WACE, LLP | 386,510 | $7,402,000 | 0.08% |
| SIGNATUREFD, LLC | 37,942 | $727,000 | 0.07% |
| A.R.T. Advisors, LLC | 38,125 | $730,000 | 0.05% |